{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:58Z","timestamp":1781920078449,"version":"3.54.5"},"reference-count":11,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v102.2243","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T07:27:31Z","timestamp":1652772451000},"page":"adv00723","source":"Crossref","is-referenced-by-count":17,"title":["Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy"],"prefix":"10.2340","volume":"102","author":[{"given":"Kana","family":"Osawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3757-7375","authenticated-orcid":false,"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuki","family":"Shimosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-6865","authenticated-orcid":false,"given":"Ryuhei","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"19050","doi-asserted-by":"crossref","unstructured":"Endo Y, Oka A, Uehara A, Toki S, Motegi SI, Ishikawa O, et al. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug. J Dermatol 2020; 47: e359-e360.","DOI":"10.1111\/1346-8138.15510"},{"key":"19051","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.15510","DOI":"10.1111\/1346-8138.15510"},{"key":"19052","doi-asserted-by":"crossref","unstructured":"Sagawa N, Watanabe Y, Mizuno Y, Takahashi S, Watanabe T, Ikeda N, et al. A case of toxic epidermal necrolysis associated with apalutamide administration. J Cutan Immunol Allergy 2020; 3: 134-135.","DOI":"10.1002\/cia2.12138"},{"key":"19053","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/cia2.12138","DOI":"10.1002\/cia2.12138"},{"key":"19054","doi-asserted-by":"crossref","unstructured":"Miyagawa A, Adachi T, Kobayashi Y, Takamiyagi S, Arakawa H, Futatsugi K, et al. Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis. J Dermatol 2022; 49: e102-e103","DOI":"10.1111\/1346-8138.16248"},{"key":"19055","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.16248","DOI":"10.1111\/1346-8138.16248"},{"key":"19056","doi-asserted-by":"crossref","unstructured":"Umemura H, Koroki Y, Iwaki Y, Imanaka K, Kamabara T, Lopez-Gitlitz A, et al. Skin rash following administration of apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study. BMC Urology 2020; 20: 139.","DOI":"10.1186\/s12894-020-00689-0"},{"key":"19057","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12894-020-00689-0","DOI":"10.1186\/s12894-020-00689-0"},{"key":"19058","doi-asserted-by":"crossref","unstructured":"Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 2014; 71: 278-283.","DOI":"10.1016\/j.jaad.2014.04.044"},{"key":"19059","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2014.04.044","DOI":"10.1016\/j.jaad.2014.04.044"},{"key":"19060","unstructured":"Chang J, Girgis L. Clinical use of anti-TNF-\u03b1 biological agents A: a guide for GPs. Aust Fam Physician 2007; 36: 1035-1038."}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2243\/4368","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2243\/4369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2243\/4368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T17:18:30Z","timestamp":1655918310000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/2243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.2243","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}